Skip Nav Destination
Issues
1 November 2018
-
Cover Image
Cover Image
A novel screen that allows the quantification of chromosome loss of human artificial chromosomes identified inhibitors of telomerase function that induce a high rate of aneuploidy. Using immunofluorescence, the authors characterized the defects in mitosis induced by the telomerase inhibitors. These include chromatin bridges and ultrafine bridges. For details, see article by Lee and colleagues on page 6282. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Reviews
Metabolism and Chemical Biology
Molecular Cell Biology
HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer
Fei Huang; Qiaoni Shi; Yuzhen Li; Linlin Xu; Chi Xu; Fenfang Chen; Hai Wang; Hongwei Liao; Zai Chang; Fang Liu; Xiang H.-F. Zhang; Xin-Hua Feng; Jing-Dong J. Han; Shiwen Luo; Ye-Guang Chen
Author Choice
Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential
Mariana Reis-Sobreiro; Jie-Fu Chen; Tatiana Novitskaya; Sungyong You; Samantha Morley; Kenneth Steadman; Navjot Kaur Gill; Adel Eskaros; Mirja Rotinen; Chia-Yi Chu; Leland W.K. Chung; Hisashi Tanaka; Wei Yang; Beatrice S. Knudsen; Hsian-Rong Tseng; Amy C. Rowat; Edwin M. Posadas; Andries Zijlstra; Dolores Di Vizio; Michael R. Freeman
Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation
Jooske F. van Lidth de Jeude; Claudia N. Spaan; Bartolomeus J. Meijer; Wouter L. Smit; Tanya T.D. Soeratram; Mattheus C.B. Wielenga; B. Florien Westendorp; Amy S. Lee; Sander Meisner; Jacqueline L.M. Vermeulen; Manon E. Wildenberg; Gijs R. van den Brink; Vanesa Muncan; Jarom Heijmans
Tumor Biology and Immunology
Author Choice
Tobacco Carcinogen–Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer
Supriya Srinivasan; Tulasigeri Totiger; Chanjuan Shi; Jason Castellanos; Purushottam Lamichhane; Austin R. Dosch; Fanuel Messaggio; Nilesh Kashikar; Kumaraswamy Honnenahally; Yuguang Ban; Nipun B. Merchant; Michael VanSaun; Nagaraj S. Nagathihalli
Author Choice
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer
Sri Krishna; Peaches Ulrich; Eric Wilson; Falguni Parikh; Pooja Narang; Shanshan Yang; Amelia K. Read; Seunghee Kim-Schulze; Jin G. Park; Marshall Posner; Melissa A. Wilson Sayres; Andrew Sikora; Karen S. Anderson
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress
Brandt A. Nichols; Nathaniel W. Oswald; Elizabeth A. McMillan; Kathleen McGlynn; Jingsheng Yan; Min S. Kim; Janapriya Saha; Prema L. Mallipeddi; Sydnie A. LaDuke; Pamela A. Villalobos; Jaime Rodriguez-Canales; Ignacio I. Wistuba; Bruce A. Posner; Anthony J. Davis; John D. Minna; John B. MacMillan; Angelique W. Whitehurst
Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia
Sabrina Inselmann; Ying Wang; Susanne Saussele; Lea Fritz; Christin Schütz; Magdalena Huber; Simone Liebler; Thomas Ernst; Dali Cai; Sarah Botschek; Cornelia Brendel; Raffaele A. Calogero; Dinko Pavlinic; Vladimir Benes; Edison T. Liu; Andreas Neubauer; Andreas Hochhaus; Andreas Burchert
Translational Science
Author Choice
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer
Nagaraj S. Nagathihalli; Jason A. Castellanos; Purushottam Lamichhane; Fanuel Messaggio; Chanjuan Shi; Xizi Dai; Priyamvada Rai; Xi Chen; Michael N. VanSaun; Nipun B. Merchant
Author Choice
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer
Yeongseon Byeon; Jeong-Won Lee; Whan Soo Choi; Ji Eun Won; Ga Hee Kim; Min Gi Kim; Tae In Wi; Jae Myeong Lee; Tae Heung Kang; In Duk Jung; Young-Jae Cho; Hyung Jun Ahn; Byung Cheol Shin; Young Joo Lee; Anil K. Sood; Hee Dong Han; Yeong-Min Park
Author Choice
Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53–MDM2 Inhibitor HDM201
Sébastien Jeay; Stéphane Ferretti; Philipp Holzer; Jeanette Fuchs; Emilie A. Chapeau; Markus Wartmann; Dario Sterker; Vincent Romanet; Masato Murakami; Grainne Kerr; Eric Y. Durand; Swann Gaulis; Marta Cortes-Cros; Stephan Ruetz; Therese-Marie Stachyra; Joerg Kallen; Pascal Furet; Jens Würthner; Nelson Guerreiro; Ensar Halilovic; Astrid Jullion; Audrey Kauffmann; Emil Kuriakose; Marion Wiesmann; Michael R. Jensen; Francesco Hofmann; William R. Sellers
Author Choice
Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG24-DFO[89Zr] for Tumor-Specific PET/CT Imaging
Stefan Stangl; Lorenzo Tei; Francesco De Rose; Sybille Reder; Jonathan Martinelli; Wolfgang Sievert; Maxim Shevtsov; Rupert Öllinger; Roland Rad; Markus Schwaiger; Calogero D'Alessandria; Gabriele Multhoff
Author Choice
Systematic Analysis of Compounds Specifically Targeting Telomeres and Telomerase for Clinical Implications in Cancer Therapy
Hee-Sheung Lee; Mar Carmena; Mikhail Liskovykh; Emma Peat; Jung-Hyun Kim; Mitsuo Oshimura; Hiroshi Masumoto; Marie-Paule Teulade-Fichou; Yves Pommier; William C. Earnshaw; Vladimir Larionov; Natalay Kouprina
RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
Thomas F. Eleveld; Linda Schild; Jan Koster; Danny A. Zwijnenburg; Lindy K. Alles; Marli E. Ebus; Richard Volckmann; Godelieve A. Tijtgat; Peter van Sluis; Rogier Versteeg; Jan J. Molenaar
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma
Jason R. Baird; R. Bryan Bell; Victoria Troesch; David Friedman; Shelly Bambina; Gwen Kramer; Tiffany C. Blair; Terry Medler; Yaping Wu; Zhaoyu Sun; Tanja D. de Gruijl; Rieneke van de Ven; Rom S. Leidner; Marka R. Crittenden; Michael J. Gough
Convergence and Technologies
Author Choice
CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets
Ana R. Cortazar; Veronica Torrano; Natalia Martín-Martín; Alfredo Caro-Maldonado; Laura Camacho; Ivana Hermanova; Elizabeth Guruceaga; Luis F. Lorenzo-Martín; Ruben Caloto; Roger R. Gomis; Iñigo Apaolaza; Victor Quesada; Jan Trka; Antonio Gomez-Muñoz; Silvestre Vincent; Xose R. Bustelo; Francisco J. Planes; Ana M. Aransay; Arkaitz Carracedo
Population and Prevention Science
Author Choice
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer
Jingmei Li; Emilio Ugalde-Morales; Wei Xiong Wen; Brennan Decker; Mikael Eriksson; Astrid Torstensson; Helene Nordahl Christensen; Alison M. Dunning; Jamie Allen; Craig Luccarini; Karen A. Pooley; Jacques Simard; Leila Dorling; Douglas F. Easton; Soo Hwang Teo; Per Hall; Kamila Czene
Letters to the Editor
JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia—Letter
Malte von Bonin; Katharina Moll; Michael Kramer; Uta Oelschlägel; Martin Wermke; Christoph Röllig; Christian Thiede; Gerhard Ehninger; Alwin Krämer; Carsten Müller-Tidow; Ioannis Mitroulis; Martin Bornhäuser
Correction
Retractions
Advertisement